GE HealthCare Technologies Inc.
NASDAQ Global Select•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Peter J. Arduini
- Full Time Employees
- 53,000
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 500 West Monroe Street Chicago IL United States of America 60661
- IPO Date
- Dec 15, 2022
- CIK
- 0001932393
- Website
- gehealthcare.com
- Similar Companies
- Business
- GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Company News
GE HealthCare to announce second quarter 2025 results on July 30, 2025
GE HealthCare announces cash dividend for second quarter of 2025
SNN vs. GEHC: Which Stock Is the Better Value Option?
GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications
FDA Approves Expanded Indications for GE HealthCare's Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer's Patients
GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET Imaging
GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
GE Healthcare: Near-Term Margin Headwinds Priced In, Long-Term Growth Driven By New Products And M&As
GE HealthCare drives innovation in theranostics with latest technological advances
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
GE HealthCare Stock Slips Despite the Launch of bkActiv S Series
GEHC Stock Declines Despite Expansion in Precision Care Capabilities
GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions
GE HealthCare: The Demand Is Just Too Strong To Ignore
3 Things Nvidia Management Just Said That Build the Buy Case for These 3 Magnificent Hidden AI Stocks
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
GEHC Stock May Rise Following the Launch of AI-Based CleaRecon DL
GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite
GEHC Stock Surges as SIGNA Sprint MRI Redefines 1.5T Imaging Tech